These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6122494)

  • 1. The effects of some antipsychotic drugs, D-amphetamine, and reserpine on the concentration and rate of accumulation of tryptamine and 5-hydroxytryptamine in the mouse striatum.
    Juorio AV
    Can J Physiol Pharmacol; 1982 Mar; 60(3):376-80. PubMed ID: 6122494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of some neuroleptics and d-amphetamine on striatal 2-phenylethylamine in the mouse.
    Juorio AV; Greenshaw AJ; Zhu MY; Paterson IA
    Gen Pharmacol; 1991; 22(2):407-13. PubMed ID: 1676007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of caffeine on mouse striatal tryptamine.
    Juorio AV
    Eur J Pharmacol; 1985 Dec; 119(3):235-7. PubMed ID: 2419142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced changes in the formation, storage and metabolism of tyramine in the mouse.
    Juorio AV
    Br J Pharmacol; 1979 Jul; 66(3):377-84. PubMed ID: 43172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
    Juorio AV; Greenshaw AJ; Wishart TB
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):644-8. PubMed ID: 3149722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitating effect of insulin on brain 5-hydroxytryptamine metabolism.
    Kwok RP; Juorio AV
    Neuroendocrinology; 1987 Apr; 45(4):267-73. PubMed ID: 2437488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of D-amphetamine and antipsychotic drug administration on striatal tyramine levels in the mouse.
    Juorio AV
    Brain Res; 1977 Apr; 126(1):181-4. PubMed ID: 15705
    [No Abstract]   [Full Text] [Related]  

  • 9. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.
    Niddam R; Arbilla S; Scatton B; Dennis T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):123-7. PubMed ID: 4010791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptamine depletion in the rat striatum following electrolytic lesions of the substantia nigra.
    Juorio AV; Greenshaw AJ
    Brain Res; 1986 Apr; 371(2):385-9. PubMed ID: 3697767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
    Nguyen TV; Juorio AV; Greenshaw AJ
    Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of benzene and pyridine on the concentration of mouse striatal tryptamine and 5-hydroxytryptamine.
    Juorio AV; Yu PH
    Biochem Pharmacol; 1985 Oct; 34(20):3774-6. PubMed ID: 2413864
    [No Abstract]   [Full Text] [Related]  

  • 13. The distribution and turnover of tryptamine in the brain and spinal cord.
    Juorio AV; Durden DA
    Neurochem Res; 1984 Sep; 9(9):1283-93. PubMed ID: 6504238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptamine concentrations in areas of 5-hydroxytryptamine terminal innervation after electrolytic lesions of midbrain raphe nuclei.
    Juorio AV; Greenshaw AJ
    J Neurochem; 1985 Aug; 45(2):422-6. PubMed ID: 2409228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems.
    Luscombe G; Jenner P; Marsden CD
    Neuropharmacology; 1982 Dec; 21(12):1257-65. PubMed ID: 6130489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine.
    Inoue O; Tsukada H; Yonezawa H; Suhara T; Langstrom B
    Eur J Pharmacol; 1991 May; 197(2-3):143-9. PubMed ID: 1915566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pargyline, reserpine and neurotoxin lesions on [3H]tryptamine binding sites in rat brain.
    Cascio CS; Kellar KJ
    Eur J Pharmacol; 1986 Jan; 120(1):101-5. PubMed ID: 3948908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigs.
    Luscombe G; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Jun; 32(12):1857-64. PubMed ID: 6192824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.